Management of non-lipid risk factors
- Öner Özdogan, Turkey
Overweight - lifestyle and drugs
Marianne Benn, Denmark
Impact of smoking and psycosocial health
Eva Prescott, Copenhagen, Denmark
What is the best practice in secondary prevention in 2020?
- Andreas Zirlik, Germany
Management of stable coronary heart disease patients
Ulrich Laufs, Leipzig, Germany
Management of acute coronary syndrome patients
Konstantinos C. Koskinas, Switzerland
NAFLD - natural history and emerging clinical trials
- Marja-Riita Taskinen, Finland
Natural history of NAFLD
Rosalind Colemen, Chapel Hill, USA
Emerging clinical trials to combat NAFLD
Sven Franque, Antwerp, Belgium
Risk prediction in primary prevention
- Katriina Aalto-Setala, Finland
Limited sensitivity: scores underestimate risk
Børge Nordestgaard, Copenhagen, Denmark
Limited specificity: scores overestimate risk
David Nanchen, Lausanne, Switzerland
